Skip to main content
OpenTrials

Clinical trial condition

Depressive Disorder, Major

Explore clinical trials studying Depressive Disorder, Major. Study availability and eligibility vary by location and protocol.

2,290 public trials 323 recruiting studies
Refine in advanced search Browse all conditions

Depressive Disorder, Major trial results

Completed

Efficacy and Safety of SR58611 Compared to Placebo and Paroxetine

NCT00825058

Conditions
Behavior, Behavioral Symptoms, Depression, +5 more
Locations
  • Sanofi-Aventis Administrative Office Sofia, Bulgaria
  • Sanofi-Aventis Administrative Office Zagreb, Croatia
  • Sanofi-Aventis Administrative Office Prague, Czechia
  • Sanofi-Aventis Administrative Office Tallinn, Estonia
View Trial Details
Completed

Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive Disorder

NCT00855530

Conditions
Behavior, Behavioral Symptoms, Depression, +5 more
Locations
  • Sanofi-Aventis Administrative Office Buenos Aires, Argentina
  • Sanofi-Aventis Administrative Office Santiago, Chile
  • Sanofi-Aventis Administrative Office Athens, Greece
  • Sanofi-Aventis Administrative Office Causeway Bay, Hong Kong
View Trial Details
Completed

Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive Disorder

NCT00432614

Conditions
Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder, +2 more
Locations
  • Sanofi-Aventis Administrative Office Diegem, Belgium
  • Sanofi-Aventis Administrative Office Tatari, Estonia
  • Sanofi-Aventis Administrative Office Helsinki, Finland
  • Sanofi-Aventis Administrative Office Paris, France
View all 13 locations
View Trial Details
Completed

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive Disorder

NCT00321490

Conditions
Behavior, Behavioral Symptoms, Depression, +5 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Scottsdale, Arizona, United States
  • Research Site Beverly Hills, California, United States
  • Research Site San Diego, California, United States
View all 34 locations
View Trial Details
Completed

Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders

NCT00326105

Conditions
Behavior, Behavioral Symptoms, Depression, +5 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site El Centro, California, United States
  • Research Site Irvine, California, United States
  • Research Site Oceanside, California, United States
View all 56 locations
View Trial Details
Completed

Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive Disorders

NCT00326144

Conditions
Behavior, Behavioral Symptoms, Depression, +5 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Little Rock, Arkansas, United States
  • Research Site Anaheim, California, United States
  • Research Site El Centro, California, United States
View all 34 locations
View Trial Details
Completed

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder

NCT00320268

Conditions
Behavior, Behavioral Symptoms, Depression, +5 more
Locations
  • Research Site Little Rock, Arkansas, United States
  • Research Site Newport Beach, California, United States
  • Research Site Northridge, California, United States
  • Research Site Oceanside, California, United States
View all 37 locations
View Trial Details

Related conditions